Shots: BGI’s Real-Time Fluorescent RT-PCR test is now commercially available in the US for detecting SARS-CoV-2. Following the FDA’s guidance, BGI’s detection kit is eligible to be used instantly to […]readmore
Tags : Availability
Shots: The new Glucagon Emergency Kit allows clinicians flexibility and choice to treat patients experiencing severe hypoglycemia and is convenient & easy to use with the availability of the co-pay […]readmore
Shots: Teva and Celltrion launch Truxima (rituximab-abbs) injection as the first biosimilar referencing Roche’s Rituxan (rituximab) to be available in the US by the week of November 11, addressing the […]readmore
Shots: The Nourianz is now available in the US as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson’s disease experiencing motor fluctuations, re-emerge between treatment dose known as “off” […]readmore
Shots: The safety & efficacy of Emgality (120mg after an initial loading dose of 240mg) is evaluated in three P-III studies EVOLVE-1, EVOlVE-2 and REGAIN study in comparison with PBO […]readmore
Shots: Samsung Bioepis reports the expansion of its global business with the entry of its first product, Brenzys (etanercept) in Brazil through Brazil’s public health system, Sistema Único de Saúde […]readmore
Shots: The approval of Verzenio is based on results of two P-III and one P-II study. The P-III MONARCH 3 study assessing Verzenio + anastrozole/letrozole vs PBO in 493 postmenopausal […]readmore
Shots: The WAC cost of Mvasi and Kanjinti is 15% lower than their reference products i.e Avastin and Herceptin respectively. Mvasi is available at WAC of $677.40/100 mg and $2,709.60/400 […]readmore
Shots: Apple has commenced sales of the One Drop glucose monitors which closely integrates with iPhone and the Apple Watch to bring the health app-compatible diabetes management device at its […]readmore